Prostate cancer and serum PSA among users of serum lipid-lowering drugs in the Finnish prostate cancer screening trial

被引：2
|
作者：
Murtola, T.
Tammela, T.
Maeaettaenen, L.
Auvinen, A.
机构：
[1] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Dept Urol, Tampere, Finland
[3] Finnish Canc Registry, Prostate Canc Screening Study, FIN-00170 Helsinki, Finland
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60798-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [41] The Finnish prostate cancer screening trial: Analyses on the screening failures
    Kilpelainen, Tuomas P.
    Tammela, Teuvo L. J.
    Malila, Nea
    Hakama, Matti
    Santti, Henrikki
    Maattanen, Liisa
    Stenman, Ulf-Hakan
    Kujala, Paula
    Auvinen, Anssi
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (10) : 2437 - 2443
  • [42] Comments on: Antiepileptic drugs and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
    Djamgoz, Mustafa B. A.
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (07) : 1212 - 1213
  • [43] Family history in the Finnish Prostate Cancer Screening Trial
    Saarimaki, Lasse
    Tammela, Teuvo L.
    Maattanen, Liisa
    Taari, Kimmo
    Kujala, Paula M.
    Raitanen, Jani
    Auvinen, Anssi
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (09) : 2172 - 2177
  • [44] Prostate Cancer Mortality in the Finnish Randomized Screening Trial
    Kilpelainen, Tuomas P.
    Tammela, Teuvo L.
    Malila, Nea
    Hakama, Matti
    Santti, Henrikki
    Maattanen, Liisa
    Stenman, Ulf-Hakan
    Kujala, Paula
    Auvinen, Anssi
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (10): : 719 - 725
  • [45] Biological aggressiveness of prostate cancer in the Finnish screening trial
    Laurila, Marita
    Tammela, Teuvo L. J.
    Auvinen, Anssi
    Isola, Jorma
    Visakorpi, Tapio
    Luukkaala, Tiina
    Maatanen, Liisa
    Ruutu, Mirja
    Ala-Opas, Martti
    Mildh, Markus
    Martikainen, Paula
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 547 - 552
  • [46] Biological aggressiveness of prostate cancer in the Finnish screening trial
    Laurila, M
    Tammela, TLJ
    Auvinen, A
    Isola, J
    Visakorpi, T
    Määttänen, L
    Ruutu, M
    Ala-Opas, M
    Mildh, M
    Martikainen, P
    JOURNAL OF UROLOGY, 2006, 175 (04): : 475 - 475
  • [47] Serum vitamin D and risk of prostate cancer among black men in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Layne, Tracy M.
    Weinstein, Stephanie
    Ma, Xiaomei
    Graubard, Barry I.
    Mayne, Susan T.
    Albanes, Demetrius
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03)
  • [48] Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Survival in the Finnish Prostate Cancer Screening Trial
    Veitonmaki, Thea
    Murtola, Teemu J.
    Maattanen, Liisa
    Taari, Kimmo
    Stenman, Ulf-Hakan
    Tammela, Teuvo L. J.
    Auvinen, Anssi
    PROSTATE, 2015, 75 (13): : 1394 - 1402
  • [49] Serum lipid profiles and aggressive prostate cancer
    Li, Yanjing
    Liang, Chaozhao
    Huang, Jiaoti
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (02) : 336 - 336
  • [50] Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
    Koutros, Stella
    Meyer, Tamra E.
    Fox, Stephen D.
    Issaq, Haleem J.
    Veenstra, Timothy D.
    Huang, Wen-Yi
    Yu, Kai
    Albanes, Demetrius
    Chu, Lisa W.
    Andriole, Gerald
    Hoover, Robert N.
    Hsing, Ann W.
    Berndt, Sonja I.
    CARCINOGENESIS, 2013, 34 (10) : 2281 - 2285
12345